Riverbend Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Hold
400
0.24% 110
2026
Q1
$368K Hold
400
0.21% 110
2025
Q4
$430K Buy
+400
New +$382K 0.27% 97

Other funds holding LLY

Riverbend Wealth Management's LLY Position: Q2 2026 in Review

Riverbend Wealth Management increased its Eli Lilly (LLY) stake by 9.2% in Q2 2026, buying an estimated $175K and bringing the position to 2,030 shares worth $2.44M. The position accounts for 1.22% of the portfolio, ranked #21.

Riverbend Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,229 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Riverbend Wealth Management held 2,030 shares of Eli Lilly worth $2.44M as of Q2 2026.
  • Riverbend Wealth Management bought 171 Eli Lilly shares in Q2 2026, an estimated $175K.
  • Eli Lilly made up 1.22% of Riverbend Wealth Management's portfolio in Q2 2026, its #21 holding.
  • Riverbend Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Riverbend Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.